{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:54:19Z","timestamp":1774659259752,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":78,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.ebr.2020.100357","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T19:55:44Z","timestamp":1585079744000},"page":"100357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Variable treatment response in a patient with pyridoxal N phosphate oxidase (PNPO) deficiency- understanding the paradox"],"prefix":"10.1016","volume":"14","author":[{"given":"Smilu","family":"Mohanlal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parayil Sankaran","family":"Bindu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Sureshbabu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January","key":"10.1016\/j.ebr.2020.100357_bb0005","first-page":"73","article-title":"Successful screening for Gaucher disease in high-prevalence population in Tabuleiro do Norte","volume":"1","author":"Chaves","year":"2011","journal-title":"JIMD Rep."},{"issue":"suppl 2","key":"10.1016\/j.ebr.2020.100357_bb0010","first-page":"S73","article-title":"Vitamin B6 dependent seizures","volume":"36","author":"Plecko","year":"2009","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.ebr.2020.100357_bb0015","first-page":"1","article-title":"Riboflavin has neuroprotective potential: focus on Parkinson\u2019s disease and migraine","author":"Marashly","year":"20178","journal-title":"Front Neurol"},{"key":"10.1016\/j.ebr.2020.100357_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2010.12.046","article-title":"Electroencephalographic and seizure manifestations of pyridoxal 5\u2032-phosphate-dependent epilepsy","author":"Veerapandiyan","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2020.100357_bb0025","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000000344","article-title":"Pyridoxine responsiveness in novel mutations of the PNPO gene","author":"Plecko","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2020.100357_bb0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymgmr.2016.01.004","article-title":"Pyridoxine responsive epilepsy caused by a novel homozygous PNPO mutation","volume":"6","author":"Jaeger","year":"2016","journal-title":"Mol Genet Metab Reports"},{"key":"10.1016\/j.ebr.2020.100357_bb0035","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awu051","article-title":"Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome","volume":"137","author":"M","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ebr.2020.100357_bb0040","article-title":"Partial pyridoxine responsiveness in PNPO deficiency","author":"Philip","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ebr.2020.100357_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awq143","article-title":"Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)","author":"Mills","year":"2010","journal-title":"Brain"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986420300058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986420300058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:06:41Z","timestamp":1762906001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986420300058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":9,"alternative-id":["S2589986420300058"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2020.100357","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable treatment response in a patient with pyridoxal N phosphate oxidase (PNPO) deficiency- understanding the paradox","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2020.100357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100357"}}